We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+20.65%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
+$24.3M
(+32%)
Cap. Flow
+$6.54M
Cap. Flow
% of AUM
6.51%
Top 10 Holdings %
Top 10 Hldgs %
56.12%
Holding
218
New
50
Increased
37
Reduced
21
Closed
27
Avg Time Held Equity + Options
4.4
quarters
Top 10 Avg Time Held Equity + Options
1.9
quarters
Top 20 Avg Time Held Equity + Options
2.2
quarters
Avg Time Held Equity only
4.7
quarters
Top 10 Avg Time Held Equity only
2.6
quarters
Top 20 Avg Time Held Equity only
2.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.77M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$661K |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$653K |
| 4 |
Micron Technology
MU
|
+$610K |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$487K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.06M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$823K |
| 3 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
+$578K |
| 4 |
BVA
CORDIA BANCORP INC COM
BVA
|
+$499K |
| 5 |
Opko Health
OPK
|
+$349K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.64% |
| 2 | Miscellaneous | 21.13% |
| 3 | Healthcare | 14.92% |
| 4 | Technology | 7.13% |
| 5 | Consumer Discretionary | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Bank of America
BAC
$380B
| $39M | 38.85% |
2,491,048
| – | – |
2013 Q2
13 quarters
|
|
|
2
Bristol-Myers Squibb
BMY
$121B
| $2.56M | 2.55% |
47,500
+27,500
| +138% | +$1.77M |
2015 Q3
4 quarters
|
|
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $2.16M | 2.16% |
+10,000
| New | +$2.16M |
2016 Q3
0 quarters
|
|
4
CALL
Boston Scientific
BSX
$61.9B
| $2.14M | 2.13% |
90,000
+40,000
| +80% | +$954K |
2016 Q2
1 quarter
|
|
5
CALL
Chipotle Mexican Grill
CMG
$40B
| $2.12M | 2.11% |
+250,000
| New | +$2.06M |
2016 Q3
0 quarters
|
|
|
6
CALL
Bank of America
BAC
$380B
| $1.96M | 1.95% |
125,000
+100,000
| +400% | +$1.49M |
2015 Q2
5 quarters
|
|
7
Sarepta Therapeutics
SRPT
$1.89B
| $1.86M | 1.86% |
30,359
+5,359
| +21% | +$162K |
2016 Q2
1 quarter
|
|
8
Amazon
AMZN
$2.83T
| $1.68M | 1.67% |
40,040
| – | – |
2015 Q2
5 quarters
|
|
|
ARIA
9
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $1.52M | 1.51% |
110,900
+65,800
| +146% | +$661K |
2013 Q4
11 quarters
|
|
10
Tootsie Roll Industries
TR
$2.82B
| $1.33M | 1.32% |
48,472
| – | – |
2014 Q4
7 quarters
|
|
|
MLNX
11
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.3M | 1.29% |
+30,000
| New | +$1.33M |
2016 Q3
0 quarters
|
|
|
MLNX
12
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.3M | 1.29% |
30,000
+11,000
| +58% | +$487K |
2014 Q2
9 quarters
|
|
|
13
Boston Scientific
BSX
$61.9B
| $1.07M | 1.07% |
45,110
+20,000
| +80% | +$477K |
2013 Q2
13 quarters
|
|
|
MON
14
CALL
DELISTED
Monsanto Co
MON
| $1.02M | 1.02% |
10,000
| – | – |
2016 Q2
1 quarter
|
|
|
ACBI
15
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $974K | 0.97% |
65,000
| – | – |
2015 Q4
3 quarters
|
|
|
16
Micron Technology
MU
$1.16T
| $889K | 0.89% |
50,000
+40,000
| +400% | +$610K |
2016 Q2
1 quarter
|
|
|
LTS
17
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $889K | 0.89% |
385,000
-15,000
| -4% | -$34.9K |
2013 Q2
13 quarters
|
|
18
Broadcom
AVGO
$1.73T
| $863K | 0.86% |
50,000
+25,000
| +100% | +$418K |
2016 Q1
2 quarters
|
|
|
WIFI
19
DELISTED
Boingo Wireless, Inc.
WIFI
| $822K | 0.82% |
80,000
| – | – |
2013 Q3
12 quarters
|
|
|
20
Agios Pharmaceuticals
AGIO
$1.9B
| $792K | 0.79% |
+15,000
| New | +$653K |
2016 Q3
0 quarters
|
|
|
ARIA
21
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $753K | 0.75% |
55,000
+45,000
| +450% | +$452K |
2016 Q2
1 quarter
|
|
22
CALL
ICICI Bank
IBN
$100B
| $747K | 0.74% |
+110,000
| New | +$767K |
2016 Q3
0 quarters
|
|
23
DELISTED
Exact Sciences
EXAS
| $696K | 0.69% |
37,500
-5,000
| -12% | -$88.1K |
2016 Q2
1 quarter
|
|
24
DELISTED
Cogentix Medical, Inc.
CGNT
| $676K | 0.67% |
371,297
+125,626
| +51% | +$163K |
2015 Q2
5 quarters
|
|
25
DELISTED
bluebird bio
BLUE
| $664K | 0.66% |
757
| – | – |
2016 Q2
1 quarter
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q3 2016 Portfolio in Review
As of Q3 2016, E.E. Geduld held 218 positions worth $100M, up 32% from $76M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
E.E. Geduld deployed $6.54M of net new capital in Q3 2016, opening 50 new positions and adding to 37 existing holdings. Its largest new stake was Agios Pharmaceuticals: 15,000 shares worth $792K.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 49% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Opko Health, an estimated $349K trimmed.
- E.E. Geduld's largest Q3 2016 buy was Agios Pharmaceuticals: 15,000 shares worth $792K.
- E.E. Geduld added most to Bristol-Myers Squibb in Q3 2016, an estimated $1.77M increase.
- E.E. Geduld's biggest Q3 2016 reduction was Opko Health, cutting an estimated $349K.
- E.E. Geduld fully exited Tesla in Q3 2016, selling an estimated $1.06M.
- E.E. Geduld's ten largest holdings make up 56% of its $100M portfolio in Q3 2016.
- E.E. Geduld opened 50 new positions and closed 27 in Q3 2016.
- E.E. Geduld's portfolio value rose 32% quarter-over-quarter to $100M.
Based on E.E. Geduld's 13F filing for Q3 2016, filed 2 Nov 2016.